EPZM Annual CFF
$31.49 M
-$218.17 M-87.39%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual cash flow from financing activities is $31.49 million, with the most recent change of -$218.17 million (-87.39%) on December 31, 2021. During the last 3 years, it has fallen by -$52.72 million (-62.60%).EPZM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly CFF
-$257.00 K
-$82.72 M-100.31%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly cash flow from financing activities is -$257.00 thousand, with the most recent change of -$82.72 million (-100.31%) on June 30, 2022. Over the past year, it has dropped by -$2.40 million (-111.98%).EPZM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM CFF
$110.16 M
-$2.40 M-2.13%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM cash flow from financing activities is $110.16 million, with the most recent change of -$2.40 million (-2.13%) on June 30, 2022. Over the past year, it has dropped by -$41.83 million (-27.52%).EPZM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.4% | -112.0% | -27.5% |
| 3 y3 years | -62.6% | -142.0% | -61.5% |
| 5 y5 years | -79.8% | -176.7% | -61.5% |
EPZM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -89.0% | -100.2% | -61.5% |
Epizyme Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$257.00 K(-100.3%) | $110.16 M(-2.1%) |
| Mar 2022 | - | $82.46 M(+984.8%) | $112.56 M(+257.4%) |
| Dec 2021 | $31.49 M(-87.4%) | $7.60 M(-62.7%) | $31.49 M(-81.6%) |
| Sept 2021 | - | $20.35 M(+848.5%) | $171.28 M(+12.7%) |
| June 2021 | - | $2.15 M(+54.4%) | $152.00 M(-11.9%) |
| Mar 2021 | - | $1.39 M(-99.1%) | $172.52 M(-30.9%) |
| Dec 2020 | $249.66 M(-12.8%) | $147.39 M(>+9900.0%) | $249.66 M(+10.6%) |
| Sept 2020 | - | $1.07 M(-95.3%) | $225.81 M(+0.2%) |
| June 2020 | - | $22.67 M(-71.1%) | $225.28 M(+10.9%) |
| Mar 2020 | - | $78.53 M(-36.4%) | $203.23 M(-29.0%) |
| Dec 2019 | $286.35 M(+240.0%) | $123.54 M(>+9900.0%) | $286.35 M(+17.1%) |
| Sept 2019 | - | $543.00 K(-11.3%) | $244.54 M(+0.0%) |
| June 2019 | - | $612.00 K(-99.6%) | $244.54 M(+0.2%) |
| Mar 2019 | - | $161.65 M(+97.8%) | $244.01 M(+189.8%) |
| Dec 2018 | $84.21 M(-46.0%) | $81.74 M(>+9900.0%) | $84.21 M(+3179.3%) |
| Sept 2018 | - | $539.00 K(+534.1%) | $2.57 M(-98.3%) |
| June 2018 | - | $85.00 K(-95.4%) | $155.05 M(-0.2%) |
| Mar 2018 | - | $1.85 M(+1846.3%) | $155.30 M(-0.4%) |
| Dec 2017 | $155.87 M | $95.00 K(-99.9%) | $155.87 M(+0.0%) |
| Sept 2017 | - | $153.02 M(>+9900.0%) | $155.84 M(+5011.1%) |
| June 2017 | - | $335.00 K(-86.2%) | $3.05 M(-22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $2.42 M(+3873.8%) | $3.93 M(-97.0%) |
| Dec 2016 | $131.36 M(+0.0%) | $61.00 K(-73.4%) | $131.36 M(+0.1%) |
| Sept 2016 | - | $229.00 K(-81.2%) | $131.28 M(-0.4%) |
| June 2016 | - | $1.22 M(-99.1%) | $131.78 M(-8.4%) |
| Mar 2016 | - | $129.85 M(<-9900.0%) | $143.90 M(+9.6%) |
| Dec 2015 | $131.34 M(+26.2%) | -$11.00 K(-101.5%) | $131.34 M(-0.3%) |
| Sept 2015 | - | $729.00 K(-94.5%) | $131.72 M(-0.4%) |
| June 2015 | - | $13.34 M(-88.6%) | $132.26 M(+10.7%) |
| Mar 2015 | - | $117.28 M(>+9900.0%) | $119.46 M(+14.7%) |
| Dec 2014 | $104.11 M(+30.2%) | $377.00 K(-70.2%) | $104.11 M(+0.3%) |
| Sept 2014 | - | $1.27 M(+138.6%) | $103.83 M(+2.0%) |
| June 2014 | - | $531.00 K(-99.5%) | $101.79 M(-44.0%) |
| Mar 2014 | - | $101.94 M(>+9900.0%) | $181.75 M(+127.3%) |
| Dec 2013 | $79.95 M(+264.5%) | $94.00 K(-112.2%) | $79.95 M(+0.1%) |
| Sept 2013 | - | -$770.00 K(-101.0%) | $79.86 M(-1.0%) |
| June 2013 | - | $80.49 M(>+9900.0%) | $80.63 M(+265.5%) |
| Mar 2013 | - | $130.00 K(+2500.0%) | $22.06 M(+0.6%) |
| Dec 2012 | $21.93 M(+14.9%) | $5000.00(+66.7%) | $21.93 M(+0.0%) |
| Sept 2012 | - | $3000.00(-100.0%) | $21.93 M(+0.0%) |
| June 2012 | - | $21.92 M(>+9900.0%) | $21.92 M(>+9900.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $19.08 M | - | - |
FAQ
- What is Epizyme annual cash flow from financing activities?
- What is the all time high annual CFF for Epizyme?
- What is Epizyme annual CFF year-on-year change?
- What is Epizyme quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Epizyme?
- What is Epizyme quarterly CFF year-on-year change?
- What is Epizyme TTM cash flow from financing activities?
- What is the all time high TTM CFF for Epizyme?
- What is Epizyme TTM CFF year-on-year change?
What is Epizyme annual cash flow from financing activities?
The current annual CFF of EPZM is $31.49 M
What is the all time high annual CFF for Epizyme?
Epizyme all-time high annual cash flow from financing activities is $286.35 M
What is Epizyme annual CFF year-on-year change?
Over the past year, EPZM annual cash flow from financing activities has changed by -$218.17 M (-87.39%)
What is Epizyme quarterly cash flow from financing activities?
The current quarterly CFF of EPZM is -$257.00 K
What is the all time high quarterly CFF for Epizyme?
Epizyme all-time high quarterly cash flow from financing activities is $161.65 M
What is Epizyme quarterly CFF year-on-year change?
Over the past year, EPZM quarterly cash flow from financing activities has changed by -$2.40 M (-111.98%)
What is Epizyme TTM cash flow from financing activities?
The current TTM CFF of EPZM is $110.16 M
What is the all time high TTM CFF for Epizyme?
Epizyme all-time high TTM cash flow from financing activities is $286.35 M
What is Epizyme TTM CFF year-on-year change?
Over the past year, EPZM TTM cash flow from financing activities has changed by -$41.83 M (-27.52%)